ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Abbott Showcases World’s First Dual Chamber Leadless Pacemaker in National Media Tour Featuring Patient Story with YourUpdateTV

NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- A revolutionary advancement in cardiac care is changing what’s possible for people living with slow or abnormal heart rhythms. On October 13th, Abbott partnered with D S Simon Media for a special media tour featuring Karen Pekowitz, one of the first U.S. recipients of the AVEIR™ DR Dual Chamber Leadless Pacemaker System.

Millions of Americans rely on pacemakers to keep their hearts in rhythm, but traditional pacemakers involve implanted wires (called leads) running from the device into the heart, requiring surgery for the initial implantation and repeated surgeries for battery replacements. The wires and the surgery carry risk of complications. Abbott’s FDA-approved AVEIR DR system introduces a major shift in care by removing those wires entirely.

This new technology is the world’s first dual chamber leadless pacemaker system, designed for the more than 80% of patients who need pacing in both the upper and lower chambers of the heart. AVEIR DR system consists of two devices, one for the upper chamber, one for the lower chamber. Each device is roughly one-tenth the size of a standard pacemaker and smaller than an AAA battery, the tiny, wireless devices are implanted directly into the heart through a minimally invasive procedure and remain invisible to the outside world.

The system uses Abbott’s innovative i2i™ communication technology to synchronize the heart’s chambers beat-to-beat, enabling natural rhythm support without the traditional hardware that restricts movement and lifestyle.

Karen Pekowitz, 50, a teacher and mother from Boston, spent more than three decades dependent on conventional pacemakers after being diagnosed with congenital heart block at age 17. Multiple surgeries, battery replacements, and wire-related concerns affected every aspect of her life.

In January 2024, Karen received the AVEIR DR dual chamber leadless pacemaker system and has since experienced a renewed sense of security and independence — demonstrating the promise of this breakthrough for future patients.

During the media tour, Karen shared her personal experience while helping viewers understand:

  • How dual chamber leadless pacing differs from traditional pacemakers
  • The reduced risk of complications and shorter recovery times
  • What this breakthrough means for the future of cardiac rhythm care

For more information, visit CARDIOVASCULAR.ABBOTT/PACEMAKERS

About YourUpdateTV: YourUpdateTV is a property of D S Simon Media. The video included and release were part of a media tour that was produced by D S Simon Media on behalf of Abbott.

Media Contact:
Michael O’Donnell
D S Simon Media
212-736-2727
modonnell@dssimon.com 

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/67236ae2-1569-4c42-9585-eeefb69a127a


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.53
+0.42 (0.18%)
AAPL  278.78
-1.92 (-0.68%)
AMD  217.97
+1.99 (0.92%)
BAC  53.95
+0.07 (0.13%)
GOOG  322.09
+3.70 (1.16%)
META  673.42
+11.89 (1.80%)
MSFT  483.16
+2.32 (0.48%)
NVDA  182.41
-0.97 (-0.53%)
ORCL  217.58
+3.25 (1.52%)
TSLA  455.00
+0.47 (0.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.